[急慢性心力衰竭患者随访:风险分层使途径多样化]。

IF 0.7 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS
Samuela Carigi, Vittoria Rizzello, Renata De Maria, Raul Limonta, Francesco Orso, Matteo Bianco, Luisa De Gennaro, Maria Vittoria Matassini, Paolo Manca, Concetta Di Nora, Maria Denitza Tinti, Vittorio Palmieri, Alessandro Navazio, Giovanna Geraci, Furio Colivicchi, Massimo Grimaldi, Fabrizio Oliva, Mauro Gori
{"title":"[急慢性心力衰竭患者随访:风险分层使途径多样化]。","authors":"Samuela Carigi, Vittoria Rizzello, Renata De Maria, Raul Limonta, Francesco Orso, Matteo Bianco, Luisa De Gennaro, Maria Vittoria Matassini, Paolo Manca, Concetta Di Nora, Maria Denitza Tinti, Vittorio Palmieri, Alessandro Navazio, Giovanna Geraci, Furio Colivicchi, Massimo Grimaldi, Fabrizio Oliva, Mauro Gori","doi":"10.1714/4464.44613","DOIUrl":null,"url":null,"abstract":"<p><p>Heart failure is a syndrome with a high clinical and healthcare impact. Currently, the incidence in Europe is approximately 5/1000 people/year in the adult population, with a prevalence of 1-2%. The prognosis is burdened by a still high mortality and hospitalization rate. The phase immediately following the hospitalization is defined as the \"vulnerable period\" because it is characterized by the greatest number of clinical events: 30% risk of rehospitalization and 10% risk of death. Taking care of the patients in this phase is crucial and must be accompanied by a risk stratification process, essential for planning a follow-up that is as personalized as possible, also necessary for resource optimization. In the chronic phase of the disease, risk stratification appears similarly important, as it could represent a support tool in the patient's transition from hospital to the community. The aims of this paper are to review the recommendations for the follow-up of the European and American guidelines, describe the tools available to the clinician to stratify the prognosis and diversify the pathway, and finally hypothesize a follow-up scheme both in the post-acute and chronic phases.</p>","PeriodicalId":12510,"journal":{"name":"Giornale italiano di cardiologia","volume":"26 4","pages":"237-250"},"PeriodicalIF":0.7000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Follow-up of patients with acute and chronic heart failure: risk stratification to diversify the pathway].\",\"authors\":\"Samuela Carigi, Vittoria Rizzello, Renata De Maria, Raul Limonta, Francesco Orso, Matteo Bianco, Luisa De Gennaro, Maria Vittoria Matassini, Paolo Manca, Concetta Di Nora, Maria Denitza Tinti, Vittorio Palmieri, Alessandro Navazio, Giovanna Geraci, Furio Colivicchi, Massimo Grimaldi, Fabrizio Oliva, Mauro Gori\",\"doi\":\"10.1714/4464.44613\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Heart failure is a syndrome with a high clinical and healthcare impact. Currently, the incidence in Europe is approximately 5/1000 people/year in the adult population, with a prevalence of 1-2%. The prognosis is burdened by a still high mortality and hospitalization rate. The phase immediately following the hospitalization is defined as the \\\"vulnerable period\\\" because it is characterized by the greatest number of clinical events: 30% risk of rehospitalization and 10% risk of death. Taking care of the patients in this phase is crucial and must be accompanied by a risk stratification process, essential for planning a follow-up that is as personalized as possible, also necessary for resource optimization. In the chronic phase of the disease, risk stratification appears similarly important, as it could represent a support tool in the patient's transition from hospital to the community. The aims of this paper are to review the recommendations for the follow-up of the European and American guidelines, describe the tools available to the clinician to stratify the prognosis and diversify the pathway, and finally hypothesize a follow-up scheme both in the post-acute and chronic phases.</p>\",\"PeriodicalId\":12510,\"journal\":{\"name\":\"Giornale italiano di cardiologia\",\"volume\":\"26 4\",\"pages\":\"237-250\"},\"PeriodicalIF\":0.7000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Giornale italiano di cardiologia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1714/4464.44613\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Giornale italiano di cardiologia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1714/4464.44613","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

心力衰竭是一种具有很高临床和医疗影响的综合征。目前,欧洲成年人的发病率约为5/1000人/年,患病率为1-2%。死亡率和住院率仍然很高,对预后的影响很大。住院后的阶段被定义为“脆弱期”,因为其特点是临床事件最多:30%的再次住院风险和10%的死亡风险。在这一阶段照顾患者是至关重要的,必须伴随着风险分层过程,这对于规划尽可能个性化的随访至关重要,也是资源优化所必需的。在疾病的慢性期,风险分层似乎同样重要,因为它可能是患者从医院过渡到社区的一种支持工具。本文的目的是回顾欧洲和美国指南的随访建议,描述临床医生可用于预后分层和多样化途径的工具,并最终假设急性期和慢性期的随访方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
[Follow-up of patients with acute and chronic heart failure: risk stratification to diversify the pathway].

Heart failure is a syndrome with a high clinical and healthcare impact. Currently, the incidence in Europe is approximately 5/1000 people/year in the adult population, with a prevalence of 1-2%. The prognosis is burdened by a still high mortality and hospitalization rate. The phase immediately following the hospitalization is defined as the "vulnerable period" because it is characterized by the greatest number of clinical events: 30% risk of rehospitalization and 10% risk of death. Taking care of the patients in this phase is crucial and must be accompanied by a risk stratification process, essential for planning a follow-up that is as personalized as possible, also necessary for resource optimization. In the chronic phase of the disease, risk stratification appears similarly important, as it could represent a support tool in the patient's transition from hospital to the community. The aims of this paper are to review the recommendations for the follow-up of the European and American guidelines, describe the tools available to the clinician to stratify the prognosis and diversify the pathway, and finally hypothesize a follow-up scheme both in the post-acute and chronic phases.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Giornale italiano di cardiologia
Giornale italiano di cardiologia CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
1.10
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信